Condition
Urinary Frequency (UF)
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Active Not Recruiting1
Not Yet Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07335484Not ApplicableNot Yet Recruiting
Aquarius Pilot Study to Evaluate the New Axonics Trial System
NCT06789406Not ApplicableRecruiting
PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
NCT06186765Not ApplicableActive Not Recruiting
F15 Recharge Free Axonics SNM System Clinical Study
Showing all 3 trials